Cannabis Cos. Adopting Biotech's Patent Playbook

By Brett Schuman and Khurram Naik (January 25, 2019, 3:29 PM EST) -- Cannabis legalization marches forward. Thirty-one states and the District of Columbia have legalized the medical use of marijuana, and 10 states as well as the District of Columbia have legalized recreational use of marijuana. It's widely estimated that in the United States, this industry with an estimated $11 billion in 2018 revenue will grow to as much as $75 billion by 2030.[1] As cannabis products become mainstream, there is a question as to whether cannabis companies will use tools of traditional biotechnology companies to respond to competition. Recent developments suggest that cannabis companies will leverage patent disputes and U.S. Food and Drug Administration regulatory action to hold or expand terrain in this developing area....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.

A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!